Guideline / position statementindependent cross-checkfull text checked★ key study I-INS-133 in-depth review
European and US consensus 2026 on type 1 diabetes in adults
The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Overview
Holt RIG et al.. Diabetologia 2026 · PMID 42747450 · DOI 10.1007/s00125-026-06833-z
Lifelong insulin is essential in type 1 diabetes, and everyone with type 1 diabetes should be able to test glucose and ketones.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Update guidance on adult T1D care.
- How was the study done?
Consensus report.
- How many people, animals or samples were studied?
Not applicable.
- What was actually found?
Insulin lifelong and essential; ketone testing for all.
- How large was the observed effect?
Not applicable.
- What do the results mean in everyday life?
People with type 1 diabetes must never stop insulin.
- What are the study's limitations?
Consensus.
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
European (EASD) guidance.
- What can explicitly not be concluded from this study?
Not applicable.
Scientific in-depth review
1. Full reference
- Authors
- Holt RIG et al.
- Journal
- Diabetologia
- Year
- 2026
- Identifier
- PMID 42747450 DOI 10.1007/s00125-026-06833-z
- Verification
- verified – PubMed efetch 2026-10-26; Crossref 2026-10-26; full text read at the Springer URL
- Retracted
- no
- Corrections
ErratumIn Diabetologia 2026 Sep 30 (doi 10.1007/s00125-026-06893-1); not a retraction
- Extent checked
- full text
- Conflicts of interest and funding
ADA and EASD; disclosures in report.
2. Research question
How should adults with T1D be managed?
3. Study design and population
- Study design
- Guideline / position statement – International consensus report (ADA/EASD)
- Population
Adults with T1D
- Country
Europe/USA
- Period
2026
- Sample size
Not applicable
- Inclusion and exclusion criteria
Not applicable
4. Methods and endpoints
- Exposure / intervention
Not applicable
- Comparator
Not applicable
- Endpoints
Recommendations
- Statistical methods
Not applicable
5. Actual results
- Results
Key point: 'Lifelong insulin therapy is essential in type 1 diabetes'. All individuals require capillary glucose testing supplies and a means of testing blood or urine ketones; ketone measurement is important during illness or hyperglycaemia to prevent and/or treat DKA; 'If left untreated, ketosis can lead to progressive dehydration and DKA'. DKA precipitants include intercurrent illness, stress, omission or under-dosing of insulin and SGLT2 inhibitors. Misdiagnosis of adult T1D as T2D delays insulin and increases DKA risk; ketosis-prone T2D exists.
- Absolute risks
not applicable
- Authors' conclusion
Lifelong insulin is essential in T1D.
6. Strengths
- Current, evidence-graded recommendations
7. Weaknesses
- Consensus elements; partly expert opinion
8. Risk of bias
- Orienting tool
- none applicable
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- not assessable
- Rationale
Guideline; graded recommendations from systematic evidence review.
9. Assessment of the statistical interpretation
Not applicable
10. Relevance to the specific claim
Most current joint European/US statement that insulin is lifelong and essential in T1D and that ketone monitoring prevents DKA.
11. Independent contrary findings
12. Transferability to Germany and Europe
Directly European (EASD).
13. Overall methodological judgement
Current authoritative consensus.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | not assessable |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | unknown |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
15. Linked fact checks
- There is no such thing as type 1 diabetes; 'type 1' is a state of high sugar seen mainly in athletes with high needs; type 1 patients do not develop complications; insulin before puberty is a catastrophe (short stature, thyroid problems, cysts). – Studies contradicting or limiting the claim
- Insulin is not needed for glucose to enter cells (the HbA1c inside red blood cells proves it); insulin therefore does not treat diabetes but 'starves' cells, especially the brain, of sugar. – Studies contradicting or limiting the claim
- Laboratory values such as blood glucose and acetone are only signs of the body's changing strategy and not causes; there is no need to measure glucose or blood pressure. – Studies contradicting or limiting the claim
- Archive conclusion: insulin is indispensable in type 1 diabetes; in type 2 diabetes, evidence supports caution with intensive dosing, prioritising metformin, weight loss and dietary change before insulin escalation, and aiming for moderate rather than near-normal HbA1c; this is not the same as rejecting insulin. – Studies supporting the claim